Terms: = Brain cancer AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223 AND Treatment
18 results:
1. Bioconjugate-loaded solid lipid nanoparticles for enhanced anticancer drug delivery to brain cancer cells: An
Jain P; Pandey V; Soni V
Indian J Med Res; 2022 Jul; 156(1):139-148. PubMed ID: 36510906
[TBL] [Abstract] [Full Text] [Related]
2. Downregulated ferroptosis-related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma.
Yao L; Li J; Zhang X; Zhou L; Hu K
CNS Neurosci Ther; 2022 Dec; 28(12):2104-2115. PubMed ID: 35962621
[TBL] [Abstract] [Full Text] [Related]
3. Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis.
Liu Y; Xu Z; Jin T; Xu K; Liu M; Xu H
Med Sci Monit; 2020 Jun; 26():e921947. PubMed ID: 32484805
[TBL] [Abstract] [Full Text] [Related]
4. [Stereotactic body radiotherapy: Passing fad or revolution?].
Vallard A; Vial N; Jmour O; Rehailia-Blanchard A; Trone JC; Sotton S; Daguenet E; Guy JB; Magné N
Bull Cancer; 2020 Feb; 107(2):244-253. PubMed ID: 31864665
[TBL] [Abstract] [Full Text] [Related]
5. Celastrol-induced degradation of fancd2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin.
Metselaar DS; Meel MH; Benedict B; Waranecki P; Koster J; Kaspers GJL; Hulleman E
EBioMedicine; 2019 Dec; 50():81-92. PubMed ID: 31735550
[TBL] [Abstract] [Full Text] [Related]
6. Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response.
Zakaria R; Platt-Higgins A; Rathi N; Crooks D; Brodbelt A; Chavredakis E; Lawson D; Jenkinson MD; Rudland PS
Br J Cancer; 2016 May; 114(10):1101-8. PubMed ID: 27100728
[TBL] [Abstract] [Full Text] [Related]
7. Covalent DNA-Protein Cross-Linking by Phosphoramide Mustard and Nornitrogen Mustard in Human Cells.
Groehler A; Villalta PW; Campbell C; Tretyakova N
Chem Res Toxicol; 2016 Feb; 29(2):190-202. PubMed ID: 26692166
[TBL] [Abstract] [Full Text] [Related]
8. Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition.
Wiegmans AP; Yap PY; Ward A; Lim YC; Khanna KK
Mol Cancer Ther; 2015 Oct; 14(10):2321-31. PubMed ID: 26294743
[TBL] [Abstract] [Full Text] [Related]
9. KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease.
Maes T; Mascaró C; Ortega A; Lunardi S; Ciceri F; Somervaille TC; Buesa C
Epigenomics; 2015; 7(4):609-26. PubMed ID: 26111032
[TBL] [Abstract] [Full Text] [Related]
10. Preoperative radiologic classification of convexity meningioma to predict the survival and aggressive meningioma behavior.
Liu Y; Chotai S; Chen M; Jin S; Qi ST; Pan J
PLoS One; 2015; 10(3):e0118908. PubMed ID: 25786236
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF
Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721
[TBL] [Abstract] [Full Text] [Related]
12. BRCA1, fancd2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells.
Burdak-Rothkamm S; Rothkamm K; McClelland K; Al Rashid ST; Prise KM
Cancer Lett; 2015 Jan; 356(2 Pt B):454-61. PubMed ID: 25304378
[TBL] [Abstract] [Full Text] [Related]
13. fancd2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents.
Patil AA; Sayal P; Depondt ML; Beveridge RD; Roylance A; Kriplani DH; Myers KN; Cox A; Jellinek D; Fernando M; Carroll TA; Collis SJ
Oncotarget; 2014 Aug; 5(15):6414-24. PubMed ID: 25071006
[TBL] [Abstract] [Full Text] [Related]
14. Proton beam therapy: a fad or a new standard of care.
Merchant TE; Farr JB
Curr Opin Pediatr; 2014 Feb; 26(1):3-8. PubMed ID: 24322719
[TBL] [Abstract] [Full Text] [Related]
15. Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour.
Khan F; Amatya B
J Neurooncol; 2013 Feb; 111(3):355-66. PubMed ID: 23292152
[TBL] [Abstract] [Full Text] [Related]
16. Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
Chung TT; Evanson J; Walker D; Akker SA; Besser GM; Monson JP; Grossman AB; Drake WM
Clin Endocrinol (Oxf); 2008 Jun; 68(6):965-9. PubMed ID: 18031317
[TBL] [Abstract] [Full Text] [Related]
17. The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents.
Chen CC; Taniguchi T; D'Andrea A
J Mol Med (Berl); 2007 May; 85(5):497-509. PubMed ID: 17221219
[TBL] [Abstract] [Full Text] [Related]
18. Staurosporine-induced activation of caspase-3 is potentiated by presenilin 1 familial Alzheimer's disease mutations in human neuroglioma cells.
Kovacs DM; Mancini R; Henderson J; Na SJ; Schmidt SD; Kim TW; Tanzi RE
J Neurochem; 1999 Dec; 73(6):2278-85. PubMed ID: 10582585
[TBL] [Abstract] [Full Text] [Related]
